HPRT1 and head and neck squamous cell carcinoma: A recent study suggests that the overexpression of HPRT1 is correlated with the poor clinical outcome of HNSCC and can be used as a meaningful prognostic marker and therapeutic target (Ahmadi et al., 2021).